Coronary Artery Bypass, Mitral Valve Annuloplasty, Mitral Valve Insufficiency
Conditions
Brief summary
This study aimed to compare the efficacy of isolated coronary artery bypass grafting and coronary artery bypass grafting + mitral valve repair in moderate ischemic mitral regurgitation patients through a cohort and explore the potential risk factors of the clinical outcomes.
Interventions
PROCEDUREmitral valve repair
coronary artery bypass grafting concomitant mitral valve repair
Sponsors
China National Center for Cardiovascular Diseases
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Adult coronary artery disease patients complicated with moderate ischemic mitral regurgitation. 2. undergoing coronary artery bypass grafting with or without mitral valve repair.
Exclusion criteria
1. patients under the age of 18 years, 2. patients complicated with more than moderate ischemic mitral regurgitation or undergoing mitral valve replacement, 3. patients complicated with primary mitral valve disease other than ischemic mitral regurgitation, such as rheumatic mitral regurgitation or mitral valve leaflet prolapse, 4. patients undergoing concomitant aortic valve procedure.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| major adverse cardiovascular and cerebrovascular events | 2years | the composite of all-cause death, rehospitalization for heart failure, non-fatal myocardial infarction, non-fatal stroke or repeat mitral valve surgery. |
Countries
China
Outcome results
None listed